Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Filings indexed 1,264 across all filing types
Latest filing 2012-05-21 Director's Dealing
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2012-05-21 English
4 Filing
Director's Dealing
2012-05-17 English
4 Filing
Director's Dealing
2012-05-17 English
4 Filing
Director's Dealing
2012-05-09 English
4 Filing
Director's Dealing
2012-05-09 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that the company announced financial and operating results for the quarter ended March 31, 2012. It also references an attached press release (Exhibit 99.1) containing the full text of the announcement. The document is relatively short (2564 characters) and primarily serves as a vehicle to announce the earnings release rather than containing detailed financial statements or analysis itself. According to the rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER). The presence of a press release announcing quarterly results aligns with the ER category rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K). Therefore, the correct classification is Earnings Release (ER).
2012-05-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.